CasLoc logo
All Cases PTAB Litigations UPC Oppositions

Collegium Pharmaceutical, Inc. v. Teva Pharmaceuticals USA Inc.

1:19-cv-00876

Overview

Case Number 1:19-cv-00876
Filing Date 2019-05-09
Status Terminated
Termination Date 2020-10-07
Court District Court, D. Delaware (ded)
Nature of Suit 830 Patent
Jurisdiction Type Federal Question
Cause of Action 35:271 Patent Infringement
Jury Demand None

Parties

Defendant

Teva Pharmaceuticals USA Inc. Operating Company

Represented By

1 Attorneys Listed

Karen Elizabeth Keller

Shaw Keller LLP

Tel: +1 (302) 298-0700

1105 North Market Street, 12th Floor, Wilmington, DE 19801

Plaintiff

Collegium Pharmaceutical, Inc. Operating Company

Represented By

6 Attorneys Listed

Oren D. Langer

Email: olanger@robinskaplan.com

Kelsey J. McElveen

UNDELIVERABLE EMAIL 6/7/2022

Kelly E. Farnan

Richards, Layton & Finger, PA

Tel: +1 (302) 651-7705

Richards, Layton & Finger, PA, One Rodney Square

Jake M. Holdreith

Email: jholdreith@robinskaplan.com

Christine Dealy Haynes

Richards, Layton & Finger

Tel: +1 (302) 651-7508

Richards, Layton & Finger, 920 North King Street

Frederick L. Cottrell , III

Richards, Layton & Finger, PA

Tel: +1 (302) 658-6541

Richards, Layton & Finger, PA, One Rodney Square

Court & Judges

Court

District Court, D. Delaware (ded)

Global Patent Family Cross-Litigation Radar

CasLoc 360Β° Radar 6 Family Members

Multi-jurisdiction dispute tracking across USPTO PTAB, U.S. Federal Courts, Unified Patent Court (UPC), and EPO Oppositions

πŸ‡ΊπŸ‡Έ
U.S. District Courts Counterparts in force
πŸ›οΈ
USPTO PTAB Trials Counterparts in force
πŸ‡ͺπŸ‡Ί
Unified Patent Court (UPC) Counterparts in force
πŸ‡©πŸ‡ͺ
European Patent Office (EPO) Counterparts in force
Worldwide Family Members (6): πŸ‡ΊπŸ‡Έ US
Parallel Proceedings Across Jurisdictions (0 found):

No active co-pending lawsuits found across other jurisdictions for this family. All related sibling filings are currently unlitigated.

Stay ahead of cross-border rulings. Subscribe for free automated docket alerts across U.S. Courts, PTAB, UPC, and EPO.

Patents Involved

1 Patent

There is a single patent involved in this case.

Patent Asset Filing & Issue Date Expiration & Term Status External Links
US10188644
Process of making stable abuse-deterrent oral formulations
Filed: 2018-04-11
Issued: 2019-01-29
Active (11.4 yrs remaining)
Expires: 2038-04-11

Patent Enforceability & Injunction Risk Assessment

Statutory Analysis
Injunction Viability (35 U.S.C. Β§ 283) Active Threat

Active Threat β€” Patent is within enforceable statutory term; injunctive relief viable.

Terminal Disclaimer & Cellect Risk Low Risk

Standard Statutory Term β€” No obviousness-type double patenting noted.

Damages Lookback Horizon 6-Yr Max Lookback

Under 35 U.S.C. Β§ 286, damages cannot accrue for infringement prior to 6 years before filing. 4th & 8th Year Maintenance Fees Paid (12th Year Window Upcoming).

Procedural Motions & Interlocutory Orders

Motion Intelligence

Total Motions

5

Dispositive

0

Granted

0

Denied

0

Pending / Review

3

Motions by Category

Procedural / Extension Motion 4 Claim Construction / Markman Filing 1

Key Dispositive Motions & Rulings

Claim Construction / Markman Filing Pending / Under Review
SCHEDULING ORDER: Case referred to the Magistrate Judge for the purpose of exploring ADR. Joinder of Parties due by 3/20/2020. Amended Pleadings due by 3/20/202...
Entry #20 • 2019-09-04 Document →
Procedural / Extension Motion Pending / Under Review
STIPULATION TO EXTEND TIME to Submit Case Management Checklist, Proposed Scheduling Order and Letter to the Court regarding the Checklist and Propsed Scheduling...
Entry #14 • 2019-07-19 Document →
Procedural / Extension Motion Pending
SO ORDERED, re 14 STIPULATION TO EXTEND TIME to Submit Case Management Checklist, Proposed Scheduling Order and Letter to the Court regarding the Checklist and ...
Entry #β€” • 2019-07-19
Procedural / Extension Motion Pending
SO ORDERED, re 12 STIPULATION TO EXTEND TIME to submit the Case Management Checklist, a proposed Scheduling Order and a letter to the Court regarding the Checkl...
Entry #β€” • 2019-07-11
Procedural / Extension Motion Pending / Under Review
STIPULATION TO EXTEND TIME to submit the Case Management Checklist, a proposed Scheduling Order and a letter to the Court regarding the Checklist and proposed S...
Entry #12 • 2019-07-08 Document →

Docket Entries

(59 total)
Pleading / Complaint

COMPLAINT for PATENT INFRINGEMENT filed against Teva Pharmaceuticals USA Inc. - Magistrate Consent Notice to Pltf. ( Filing fee $ 400, receipt number 0311-2639091.) - filed by Collegium Pharmaceutical, Inc. (Attachments: # 1 Exhibit A, # 2 Civil Cover Sheet)(nmg) (Entered: 05/10/2019)

Entry #1 • 2019-05-09
1

Notice, Consent and Referral forms re: U.S. Magistrate Judge jurisdiction. (nmg) (Entered: 05/10/2019)

Entry #2 • 2019-05-09
1

Report to the Commissioner of Patents and Trademarks for Patent/Trademark Number(s) 10,188,644. (nmg) (Entered: 05/10/2019)

Entry #3 • 2019-05-09
1

Disclosure Statement pursuant to Rule 7.1: No Parents or Affiliates Listed filed by Collegium Pharmaceutical, Inc. (nmg) (Entered: 05/10/2019)

Entry #4 • 2019-05-09
1

No Summons Issued. (nmg)

Entry #5 • 2019-05-09
1
No Actions

Track Case Updates

Automated email notifications for new filings & decisions

Identifier: •

Free service • 1-click unsubscribe anytime • Powered by CasLoc